𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

✍ Scribed by Christopher J. Earley; Alena Horská; Mona A. Mohamed; Peter B. Barker; John L. Beard; Richard P. Allen

Book ID
116884508
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
114 KB
Volume
10
Category
Article
ISSN
1389-9457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo cont
A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome
✍ Ludger Grote; Lena Leissner; Jan Hedner; Jan Ulfberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

## Abstract Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, S‐ferritin ≤

A double-blind randomized crossover tria
A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome
✍ Dr. Arthur S. Walters; Wayne A. Hening; Neil Kavey; Sudhansu Chokroverty; Steve 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

A double-blind randomized crossover study of 7.5 mg bromocriptine at bedtime versus placebo was conducted in 30-day phases (with a 2-week washout period between phases) in 6 patients with idiopathic restless legs syndrome. Five patients experienced partial subjective improvement in restlessness and

Rotigotine improves restless legs syndro
Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States
✍ Wayne A. Hening; Richard P. Allen; William G. Ondo; Arthur S. Walters; John W. W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

## Abstract This randomized, double‐blinded, placebo‐controlled trial (NCT00135993) assessed efficacy and safety of the dopamine agonist rotigotine in the treatment of idiopathic restless legs syndrome (RLS) over a 6‐month maintenance period. A total of 505 eligible participants with moderate to se